TWR 0.00% 79.5¢ tower limited ordinary shares

Ann: ASSET: TWR: TOWER Life business sold to Fide

  1. lightbulb Created with Sketch. 2
    • Release Date: 10/05/13 10:30
    • Summary: ASSET: TWR: TOWER Life business sold to Fidelity
    • Price Sensitive: No
    • Download Document  3.23KB
    					
    
    TWR
    10/05/2013 08:30
    ASSET
    
    REL: 0830 HRS Tower Limited
    
    ASSET: TWR: TOWER Life business sold to Fidelity
    
    10 May 2013
    
    Market Information
    NZX Limited
    Level 2, NZX Centre
    11 Cable Street
    Wellington
    NEW ZEALAND
    
    Company Announcements Office
    Australian Stock Exchange Limited
    Exchange Centre
    Level 6, 20 Bridge Street
    Sydney NSW 2000
    AUSTRALIA
    
    TOWER Life business sold to Fidelity
    
    TOWER Limited today announced that it has sold most of its life insurance
    business to Fidelity Life Assurance Company Limited (Fidelity Life). The
    aggregate value of the transaction for TOWER, including cash consideration
    and release of capital, is $189 million.
    
    Fidelity Life is a New Zealand owned company that specialises in life
    insurance, personal protection, business insurance, savings, investment and
    KiwiSaver.
    
    Under the agreement with Fidelity, TOWER will sell most of its
    non-participating life insurance policies and retain the capital currently
    held against those policies, releasing an aggregate amount of capital of $189
    million. In addition, TOWER will also retain its participating book and other
    run-off life insurance assets which have an embedded value of $23 million.
    The sale implies a total value of $212 million for TOWER's life insurance
    business.
    
    TOWER Group Managing Director Rob Flannagan said TOWER would now focus on
    delivering high quality general insurance products and services to customers
    in New Zealand and the Pacific Islands, leveraging off its strong market
    position and brand reputation.
    
    "We determined that now was a good time to maximise value to TOWER
    shareholders by selling this part of the life business. This concludes our
    strategic review. Going forward, we will be concentrating on growing
    shareholder value by developing and growing our specialist general insurance
    business," he said.
    
    Fidelity Life Chairman, Ian Braddock says the deal is significant for the
    company, making it the third largest life insurer in terms of in-force market
    share, and ensuring more opportunities for policy holders, staff and
    shareholders.
    
    Mr Braddock added "It is important that we have a strong New Zealand owned
    company in our financial services industry. This will give us the scale to
    expand further into the market."
    
    Mr Flannagan said the half year results presentation on 28 May will include
    details of how TOWER will apply the proceeds of the transaction, including
    the amount of capital to be returned to shareholders. At that time, TOWER
    will also provide pro-forma financial information to reflect the sale of its
    life insurance business; information relating to the ongoing capital
    structure and earnings and dividend guidance for the ongoing specialist
    general insurance business and remaining assets.
    
    Any TOWER life customers with queries can contact their adviser or call TOWER
    on 0800 754 754 for more information.
    
    The sale of TOWER's Life insurance business is subject to terms and
    conditions customary for a transaction of this type.  Subject to satisfaction
    and timing of conditions, settlement is likely to occur in July 2013.
    
    ENDS
    
    For further information, please contact:
    Rob Flannagan
    Group Managing Director
    TOWER Limited
    Tel: + 64 9 369 2188
    ARBN 088 481 234 Incorporated in New Zealand
    End CA:00236046 For:TWR    Type:ASSET      Time:2013-05-10 08:30:05
    				
 
watchlist Created with Sketch. Add TWR (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.